Zaiding Pharmaceutical's US stock market rose more than 20% before market opening
ezno
发表于 2024-5-9 17:23:06
3689
0
0
Zaiding Pharmaceutical's US stock rose more than 20% before trading, closing at $19.89; The H-share market surged by over 20.8% today, closing at HKD 15.9.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Chinese concept stocks and US stocks generally rose before the market opened, with Bilibili rising nearly 4%
- Chinese concept stocks and US stocks generally strengthened before the market opened, and Futu Holdings rose more than 5%
- Bank of America survey: US stock market expected to be the best asset of 2025 after Trump's victory!
- Pfizer plans to sell hospital drug division, company responds
- Chinese concept stocks and US stocks mostly rose before the market, with extreme discounts and a nearly 6% increase
- Most US bank stocks rise, with JPMorgan Chase exceeding 1%
- Fuguo Bank's US stock market rose nearly 3% before trading
- RBC Capital raises target prices for multiple US bank stocks
- Micron Technology's US stock fell more than 14% in pre-market trading
- Jianxun Daily | Hengrui Pharmaceutical and IDEAYA signed an authorization agreement; Liu Zhongliang, the actual controller of Weikang Pharmaceutical, has been registered
